|
Age (mean ± SD, range) (years)
|
58.0 ± 11.7 (26–87)
|
|
BMI (mean ± SD, range) (kg/m2)
|
23.6 ± 3.0 (15.1 − 35.4)
| |
|
Gender
|
|
Male
|
625 (60.0)
|
|
Female
|
417 (40.0)
|
|
Tumor size (mean ± SD, range) (mm)
|
|
Size using EGD (n = 631)
|
16.1 ± 8.0 (2–60)
|
−
|
|
Size using EUS (n = 479)
|
16.4 ± 5.9 (3–40)
|
−
|
|
Pathological size
|
−
|
21.1 ± 14.8 (1–165)
|
|
Ulcer
|
|
Positive
|
66 (6.3)
|
245 (23.5)
|
|
Negative
|
976 (93.7)
|
797 (76.5)
|
|
Tumor location
|
|
Upper third
|
146 (14.0)
|
127 (12.2)
|
|
Middle or lower third
|
896 (86.0)
|
915 (87.8)
|
|
Gross type
|
|
0-Ia
|
29 (2.8)
|
18 (1.7)
|
|
0-IIa
|
278 (26.7)
|
34 (3.3)
|
|
0-IIb
|
224 (21.5)
|
184 (17.7)
|
|
0-IIc
|
428 (41.1)
|
667 (64.0)
|
|
0-III
|
83 (8.0)
|
62 (6.0)
|
|
AGC
|
0
|
77 (7.4)
|
|
Histology
|
|
Papillary
|
1 (0.1)
|
1 (0.1)
|
|
Well differentiated
|
165 (15.8)
|
125 (12.0)
|
|
Moderately differentiated
|
260 (25.0)
|
264 (25.3)
|
|
Poorly differentiated
|
252 (24.2)
|
273 (26.2)
|
|
Signet ring cell
|
364 (34.9)
|
364 (34.9)
|
|
Mucinous
|
0
|
2 (0.2)
|
|
Carcinoma with lymphoid stroma
|
0
|
13 (1.2)
|
|
Tumor detectability in CT scan
|
|
Detectable
|
210 (20.2)
|
−
|
|
Undetectable
|
832 (79.8)
|
−
|
|
Presence of LMN in CT scan
|
|
Suspected
|
42 (4.0)
|
−
|
|
Unsuspected
|
1000 (96.0)
|
−
|
|
NLR
|
2.00 ± 1.32 (0.09 − 29.56)
|
−
|
|
Tumor depth
|
|
Mucosa
|
−
|
588 (56.4)
|
|
Submucosa
|
−
|
373 (36.0)
|
|
Proper muscle
|
−
|
56 (5.4)
|
|
Subserosa
|
−
|
10 (1.0)
|
|
Serosa invasion
|
−
|
15 (1.4)
|
|
Lymph node classification
|
|
pN0
|
−
|
968 (92.9)
|
|
pN1
|
−
|
42 (4.0)
|
|
pN2
|
−
|
23 (2.2)
|
|
pN3a
|
−
|
7 (0.7)
|
|
pN3b
|
−
|
2 (0.2)
|
|
Count of retrieved lymph nodes (mean ± SD, range)
|
−
|
32.6 ± 11.9 (5–74)
|
